EGCG (10–50 μm) was found to suppress, via ER, the estrogenic, proliferation-stimulating activity of polychlorinated biphenyl PCB 102 in estrogen-sensitive breast cancer cell line MCF-7/BOS. This evidence concerns the gene ESR1 and breast carcinoma.